MedTrace Logo

Prospective Cohort Study of Neuromyelitis Optica Spectrum Disorders (NMOSD)

NCT07266051 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 4000

Last updated 2025-12-18

No results posted yet for this study

Summary

This study aims to characterize sex hormone alterations and their potential clinical significance in NMOSD patients from Southern China through comprehensive hormonal profiling.

Conditions

  • NMOSD

Interventions

OTHER

Sex hormone assay

This study will explore and validate the characteristics of sex hormone levels in MNMOSD

OTHER

Sex hormone assay

This study will explore the comparison of sex hormone levels between a healthy control group and MNMOSD

Sponsors & Collaborators

  • Xiamen Hospital of Traditional Chinese Medicine

    lead OTHER

Principal Investigators

  • Shiyong Li · Xiamen Hospital of Traditional Chinese Medicine

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-12-31
Primary Completion
2030-07-31
Completion
2030-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07266051 on ClinicalTrials.gov